-
Signature
-
/s/ Karah Parschauer, attorney-in-fact
-
Stock symbol
-
RARE
-
Transactions as of
-
Mar 1, 2022
-
Transactions value $
-
-$215,449
-
Form type
-
4
-
Date filed
-
3/3/2022, 05:09 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
RARE |
Common Stock |
Sale |
-$215K |
-3.23K |
-8.06% |
$66.62 |
36.9K |
Mar 1, 2022 |
Direct |
F1 |
transaction |
RARE |
Common Stock |
Award |
$0 |
+14K |
+37.8% |
$0.00 |
51K |
Mar 1, 2022 |
Direct |
F2, F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
RARE |
Stock Option (Right to Buy) |
Award |
$0 |
+24.9K |
|
$0.00 |
24.9K |
Mar 1, 2022 |
Common Stock |
24.9K |
$67.37 |
Direct |
F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
EVP, Chief Technical Operations Officer and Gene Therapy Operations